165 related articles for article (PubMed ID: 18414777)
1. Impact of state and trait anxiety on the panic response to CCK-4.
Eser D; Wenninger S; Baghai T; Schüle C; Rupprecht R
J Neural Transm (Vienna); 2008 Jun; 115(6):917-20. PubMed ID: 18414777
[TBL] [Abstract][Full Text] [Related]
2. Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers.
Eser D; Leicht G; Lutz J; Wenninger S; Kirsch V; Schüle C; Karch S; Baghai T; Pogarell O; Born C; Rupprecht R; Mulert C
Hum Brain Mapp; 2009 Feb; 30(2):511-22. PubMed ID: 18095276
[TBL] [Abstract][Full Text] [Related]
3. Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.
Koszycki D; Cox BJ; Bradwejn J
Am J Psychiatry; 1993 Dec; 150(12):1881-3. PubMed ID: 8238648
[TBL] [Abstract][Full Text] [Related]
4. Trait dissociation affects the behavioral response to cholecystokinin tetrapeptide in healthy man.
Kellner M; Yassouridis A; Hua Y; Wendrich M; Naber D; Wiedemann K
Psychiatry Res; 2002 Aug; 111(1):93-6. PubMed ID: 12140124
[TBL] [Abstract][Full Text] [Related]
5. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R
J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder.
Bradwejn J; Koszycki D; Meterissian G
Can J Psychiatry; 1990 Feb; 35(1):83-5. PubMed ID: 2180549
[TBL] [Abstract][Full Text] [Related]
7. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A
J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
[TBL] [Abstract][Full Text] [Related]
8. Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.
Aluoja A; Shlik J; Vasar V; Kingisepp PH; Jagomägi K; Vasar E; Bradwejn J
Psychiatry Res; 1997 Jan; 66(1):59-67. PubMed ID: 9061804
[TBL] [Abstract][Full Text] [Related]
9. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
Bradwejn J; Koszycki D; Shriqui C
Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490
[TBL] [Abstract][Full Text] [Related]
10. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
Wiedemann K; Jahn H; Yassouridis A; Kellner M
Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
[TBL] [Abstract][Full Text] [Related]
11. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.
Tõru I; Aluoja A; Võhma U; Raag M; Vasar V; Maron E; Shlik J
Psychiatry Res; 2010 Jul; 178(2):342-7. PubMed ID: 20471107
[TBL] [Abstract][Full Text] [Related]
12. Levels of "nonclinical panic".
Cox BJ; Endler NS; Norton GR
J Behav Ther Exp Psychiatry; 1994 Mar; 25(1):35-40. PubMed ID: 7962579
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study.
Eser D; Schüle C; Baghai T; Floesser A; Krebs-Brown A; Enunwa M; de la Motte S; Engel R; Kucher K; Rupprecht R
Psychopharmacology (Berl); 2007 Jul; 192(4):479-87. PubMed ID: 17318504
[TBL] [Abstract][Full Text] [Related]
14. Discrimination between panic disorder and generalized anxiety disorder by 35% carbon dioxide challenge.
Verburg K; Griez E; Meijer J; Pols H
Am J Psychiatry; 1995 Jul; 152(7):1081-3. PubMed ID: 7793449
[TBL] [Abstract][Full Text] [Related]
15. Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings.
Bradwejn J; Koszycki D; Payeur R; Bourin M; Borthwick H
Am J Psychiatry; 1992 Jul; 149(7):962-4. PubMed ID: 1609879
[TBL] [Abstract][Full Text] [Related]
16. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.
Schunck T; Erb G; Mathis A; Gilles C; Namer IJ; Hode Y; Demaziere A; Luthringer R; Macher JP
Neuroimage; 2006 Jul; 31(3):1197-208. PubMed ID: 16600640
[TBL] [Abstract][Full Text] [Related]
17. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
Bertoglio LJ; Zangrossi H
Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
[TBL] [Abstract][Full Text] [Related]
18. Reactivity to challenge with carbon dioxide as a prospective predictor of panic attacks.
Schmidt NB; Maner JK; Zvolensky MJ
Psychiatry Res; 2007 May; 151(1-2):173-6. PubMed ID: 17395271
[TBL] [Abstract][Full Text] [Related]
19. Copeptin in CCK-4-induced panic in healthy man: Sexual dimorphisms in secretion pattern and panic response, but no correlation of copeptin with panic symptoms.
Kellner M; Zwanzger P; Rupprecht R; Eser D; Yassouridis A; Wiedemann K
Psychoneuroendocrinology; 2019 Dec; 110():104433. PubMed ID: 31525566
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
Kellner M; Wiedemann K; Yassouridis A; Levengood R; Guo LS; Holsboer F; Yehuda R
Biol Psychiatry; 2000 Jan; 47(2):107-11. PubMed ID: 10664826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
